Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Sorry, folks, but stay calm --- this is bad on the surface...

RE: Sorry, folks, but stay calm --- this is bad on the surface...

posted on Apr 21, 2006 04:42PM
consider that the article said IF YOU ASSUME the same rate of licensing fees ... but we know that Pohl has stated the early birds got sweetheart deals. So with that said, maybe we can double or triple expectations. So instead of $1 dividend in 9 years, there will be $3 - $4 dividends AND with the monies recieved PTSC will reinvent itself by buying another business (as also stated by Pohl). Other than the dilution factor which I am hoping some of you will share enlightenment, this guy is painting a very negative picture that could just as easily be fairly positive. imho
Share
New Message
Please login to post a reply